UV Flu Technologies Inc. (OTCBB: UVFT.OB) develops highly innovative air purification technology that purifies indoor air by killing airborne bacteria. The Company’s flagship product, ViraTechTM UV-400 model, utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtering to destroy harmful bacteria. Extensive independent testing by EPA and FDA certified laboratories confirms the proprietary system kills airborne bacteria at rates exceeding 99.2% on a first-pass basis.
Increased media attention and growing public concern over the rise of the H1N1 swine flu pandemic, antibiotic resistant superbugs, asthma, allergies, tuberculosis, Sick Building Syndrome and toxic mold are spurring governments, employers and homeowners to take action to safeguard their health.
UV Flu’s proven air purification technology uses high-intensity ultraviolet light (UV-C) to clean air and destroy bacteria. Its flagship ViraTechTM UV-400 product draws air in through a killing chamber cartridge where baffles provide the turbulence necessary to bring bacteria in close proximity to the special UVC lamps, allowing the germicidal UV-C to kill any bacteria present. Before exiting, the air stream passes through a gross particulate screen which removes the neutralized dust and debris. The sealed cartridge can be discarded with regular trash after 12 months of continuous operation. This is an advantage over HEPA filter products which trap but do not kill the bacteria, requiring filters to be discarded as red bag waste.
The ViraTech UV-400 unit has been laboratory tested with proven results in reducing odors and VOC’s (volatile organic compounds). Independent EPA and FDA certified laboratory testing confirms the system kills airborne bacteria at rates ranging from 99.2% to more than 99.99% on a first-pass basis. In actual operation multiple passes through the unit will occur, producing average removal rates that far exceed 99.2%.
The Company has completed the design of its second product, a smaller, lower cost version of the ViraTechTM UV-400. UV Flu expects to begin shipping the new model into commercial accounts before the end of 2010. Additional products will follow.
What Sets UV Flu Apart
- Independent lab testing confirming over 99% effectiveness eliminating bacteria.
- The ViraTech UV-400 unit has been laboratory tested with proven results in reducing odors and VOC’s (volatile organic compounds).
- U.S. Patent No. 6939397 covering highly innovative air disinfecting technology and product design.
- Environmentally friendly, energy conscious technology.
- Third party testing and certification of product as electrically and operationally safe to use, eliminating product liability issues.
- Unique replaceable cartridge design to provide continuous revenue stream throughout product lifecycle.
For more information on UV Flu Technologies, please go to www.uvflutech.com. For a copy of Analyst’s STRONG BUY Recommendation Report on UVFT, please go to www.biotechstockpick.com.
Happy trading,
Curt

![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)




